Pytho PartnersTM was founded by venture capitalists to invest in the assets of private and public healthcare companies. Because the vast majority of a biotechnology or medical device company's value is driven by just a few of its leading therapeutic candidates, we are ever vigilant in seeking out companies that cultivate products with significant market potential both in the US & Europe as well as across Asia.
As fundamental, research-oriented investors, Pytho focuses on helping to nurture portfolio companies through all phases of their development from R&D to product Sales and Marketing. We understand that it requires more than just financial support to accelerate the growth of companies. That's why our entrepreneurs gain access to our global network of scientists and business leaders who act as catalysts for further strategic partnerships and alliances. We also specialize in helping to navigate the regulatory and intellectual property hurdles of our US/European and Asian partners as they start developing these therapeutic assets internationally. We believe that great skill as well as expert knowledge are prerequisites for this investing success.